JPS5846511B2 - ２−メトキシベンズアミド誘導体 - Google Patents

２−メトキシベンズアミド誘導体

Info

Publication number
JPS5846511B2
JPS5846511B2 JP54145968A JP14596879A JPS5846511B2 JP S5846511 B2 JPS5846511 B2 JP S5846511B2 JP 54145968 A JP54145968 A JP 54145968A JP 14596879 A JP14596879 A JP 14596879A JP S5846511 B2 JPS5846511 B2 JP S5846511B2
Authority
JP
Japan
Prior art keywords
compound
methoxybenzamide
pharmacologically acceptable
derivatives
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54145968A
Other languages
English (en)
Japanese (ja)
Other versions
JPS55113762A (en
Inventor
アンリ・ナージエ
ジヤン・ピエール・カプラン
ダニエル・シヤルル・レオン・オビツツ
ドン・ピエール・ルネ・ルシアン・ジユーデイスリ
フイリツプ・ミシエール・ジヤツク・マヌーリ
ベルナール・ミツシエル・レーゾン
モーリス・ジヤルフル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Publication of JPS55113762A publication Critical patent/JPS55113762A/ja
Publication of JPS5846511B2 publication Critical patent/JPS5846511B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
JP54145968A 1975-10-14 1979-11-09 ２−メトキシベンズアミド誘導体 Expired JPS5846511B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7531334A FR2327771A2 (fr) 1975-10-14 1975-10-14 Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment

Publications (2)

Publication Number Publication Date
JPS55113762A JPS55113762A (en) 1980-09-02
JPS5846511B2 true JPS5846511B2 (ja) 1983-10-17

Family

ID=9161149

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54145968A Expired JPS5846511B2 (ja) 1975-10-14 1979-11-09 ２−メトキシベンズアミド誘導体

Country Status (2)

Country Link
JP (1) JPS5846511B2 (fr)
FR (1) FR2327771A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57186185U (fr) * 1981-05-19 1982-11-26
WO1991017144A1 (fr) * 1990-05-02 1991-11-14 Yoshitomi Pharmaceutical Industries, Ltd. Compose amide, utilisation pharmaceutique de ce compose et nouvelles pyrrolidinemethyl-amines 1-substituee

Also Published As

Publication number Publication date
FR2327771B2 (fr) 1982-08-20
FR2327771A2 (fr) 1977-05-13
JPS55113762A (en) 1980-09-02

Similar Documents

Publication Publication Date Title
KR870000809B1 (ko) 1,4-디하이드로피리딘의 제조방법
CS228917B2 (en) Method of preparing substituted derivatives of 1,4-dihydropyridine
IE47965B1 (en) Cycloalkyltriazoles and process for obtaining same
JPS60255764A (ja) （ｒ）‐アルフア‐エチル‐２‐オキソ‐１‐ピリジンアセトアミド及びその製法並びに該化合物を含有する製薬組成物
FR2573075A1 (fr) Nouvelles (pyridyl-2)-1 piperazines, leur procede de preparation et leur application en therapeutique
JPH037263A (ja) アミノベンゼンスルホン酸誘導体
HU191220B (en) Process for producing dihydropyridine derivatives and pharmaceutical compositions of antiischemic and vasodilatant activity containing them
DK163181B (da) Analogifremgangsmaade til fremstilling af n,n'-di(arylalkylen)alkylendiaminer eller farmaceutisk acceptable salte deraf
JPH0367071B2 (fr)
HU198014B (en) Process for producing antiarithmic sulfonamides and pharmaceutical compositions containing them
EP0104614B1 (fr) Dérivés du phénylpipérazine et leur procédé de préparation
PT96952A (pt) Processo para a preparacao de derivados de 4-(aminometil)-piperidina e de composicoes farmaceuticas que os contem
EP0093521B1 (fr) Dérivés de la quinoléine
US4145422A (en) Aminomethylene oxindoles
JPS5846511B2 (ja) ２−メトキシベンズアミド誘導体
JP2011213718A (ja) アミノ酸誘導体を含有する医薬及び該誘導体の製造方法
KR0139201B1 (ko) 아미노벤젠술폰산 유도체
JPS62281860A (ja) アルキレンアミノアルキレン　ヘテロ原子基を有するジヒドロ−３，５−ジカルボキシレ−ト
DK170047B1 (da) Med basiske heterocycliske grupper substituerede 5-halogen-thienoisothiazol-3(2H)-on-1,1-dioxider og salte deraf, fremgangsmåde til fremstilling af sådanne forbindelser, farmaceutiske præparater indeholdende disse forbindelser og forbindelsernes anvendelse ved fremstilling af lægemidler til behandling af angsttilstande
KR910003711B1 (ko) 2-(n-피롤리디노)-3-이소부톡시-n-치환된 페닐-n-벤질-프로필아민의 제조방법
JP3045354B2 (ja) チオキサンテノン類およびその抗腫瘍剤
JPH05506654A (ja) １，５―ベンゾチアゼピノン誘導体、その製法および医薬品用途
CS207639B2 (en) Method of making the new derivatives of dibenzo d,g 1,3,6 dioxazocine
KR840002139B1 (ko) 벤조퀴놀리진의 제조방법
FI85491C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fosfonsyraderivat.